GSK press releases Follow GSK presents first global data for Ris-Rez in extensive-stage small cell lung cancer The EMBOLD PanTumour-101 trial showed positive anti-tumour activity and a manageable safety profile. https://www.gsk.com/en-gb/media/press-releases/gsk-presents-first-global-data-for-ris-rez-in-extensive-stage-small-cell-lung-cancer/ gsk.com
